Fintel reports that on January 9, 2025, Morgan Stanley upgraded their outlook for Vir Biotechnology (NasdaqGS:VIR) from Equal ...

This week brought yet another twist in the saga around Textor's shareholding in the Premier League club — this is what we ...

Overall, investors appear to view the incoming administration favorably for the sector, as the NSE Nifty IT Index has ...

Profound funding shift might contribute to huge investment needed for data centres, energy and reshoring of industry ...

The broader market, comprising mid-small cap indices, reflected the overall negative sentiment in the market with losses of 0 ...

Shares of TCS surged 4.7% after reporting a 12% rise in Q3 net profit to Rs 12,380 crore. Revenue grew 5.6% YoY, driven by ...

Companies seeking to benefit from campaign promises to cut regulations and taxes are ditching diversity and climate ...

With limited growth visibility, a potential cut to consensus numbers, and high valuations, analysts expect the stock to ...

Morgan Stanley have downgraded Tata Elxsi stock to an "underweight" rating and reduced their target price to Rs 6,000 per ...

The bank is currently the worst-performing member of the big four. The post Why is the Westpac share price being hit so hard ...

Aimco is exploring strategic options, including selling the entire company, as part of efforts to unlock shareholder value ...

Traders and dealmakers are looking at their biggest bonus increases since the pandemic, at 10 per cent or more. Read more at ...